Resource Center: pharmacology, assessment

This article is an intervention review. It reviews behavioral and pharmacological interventions for helping users quit smokeless tobacco.

The burden of suffering due to tobacco use is staggering, and irreconcilable with the relative social and medical complacency with which it is treated. Smoking is the leading cause of preventable premature death in our society, claiming more lives around the world each year than war: it may be the most important public health issue of our time., Since most smokers see a physician each year, and most smokers report a desire to quit, primary care clinicians are well positioned to assist smokers in their cessation efforts. It is essential to provide effective cessation intervention for all smokers at each visit. (From their website)

This manual has been prepared by the Drug Enforcement Administration, Office of Diversion Control, to assist practitioners (physicians, dentists, veterinarians, and other registrants authorized to prescribe, dispense, and administer controlled substances) in their understanding of the Federal Controlled Substances Act and its implementing regulations as they pertain to the practitioner’s profession.

A site for physicians, researchers, pharmacists, nurses, and counselors to learn more about buprenorphine as a medication for opioid addiction treatment.

Monograph 2: Smokeless Tobacco or Health: An International Perspective covers Epidemiology, Clinical and Pathological Effects, Carcinogenesis, Nicotine Effects and Addiction, Prevention, Cessation, and Policy.